Clinical Trials Directory

Trials / Unknown

UnknownNCT03975452

Volume De-escalation in Neoadjuvant Radiochemotherapy of Rectal Cancer

Phase II Study on Volume De-escalation in Neoadjuvant Radiochemotherapy of Rectal Cancer

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
52 (actual)
Sponsor
Campus Bio-Medico University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study outlines a clinical prospective protocol consisting of preoperative chemoradiation in locally advanced rectal cancer, without elective pelvic nodal irradiation. The proposal to exclude lateral spaces from the target volume is based on the assumption that the radiological evidence of recurrence in the lateral lymph nodes is shown to be below 5%. In the study all patients underwent an accurate pre-treatment work-up including total body CT, pelvic MRI and 18-fluorodeoxyglucose PET/CT, in order to include patients without evidence of disease in lateral lymph nodes. The primary endpoint of the study was the reduction of gastrointestinal toxicity; secondary endpoints were the pathological complete response (pCR), the local control (LC) rate, the overall survival (OS) and the disease-free survival (DFS).

Detailed description

Patients affected by histologically proven rectal cancer were considered for enrollment in a prospective protocol that included preoperative CRT and surgical treatment. All patients underwent pre-treatment work-up (clinical examination, pancolonoscopy with biopsy, total body CT scan, pelvic MRI, and whole body 18-fluorodeoxyglucose PET/CT scan). Eligible patients had primary resectable cT2-low lying-T3, N0-N1 adenocarcinoma of the rectum, without evidence of disease in lateral lymph nodes. Additional eligibility criteria included performance status as well as liver, kidney, and bone marrow function that allowed for long-course CRT, older than 18 years, and no distant metastases.

Conditions

Interventions

TypeNameDescription
RADIATIONReduced radiation volumesPatient treated with reduced radiation volumes with the exclusion of elective pelvic nodal irradiation

Timeline

Start date
2007-11-01
Primary completion
2016-08-01
Completion
2019-12-01
First posted
2019-06-05
Last updated
2019-06-05

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT03975452. Inclusion in this directory is not an endorsement.

Volume De-escalation in Neoadjuvant Radiochemotherapy of Rectal Cancer (NCT03975452) · Clinical Trials Directory